Mayo Clinical Oncology Research Training Program

梅奥临床肿瘤学研究培训计划

• 批准号: 6661324
• 负责人: LYNN C. HARTMANN
• 金额: $ 50.16万
• 依托单位: MAYO CLINIC ROCHESTER
• 依托单位国家: 美国
• 财政年份: 2001
• 资助国家: 美国
• 起止时间: 2001-09-25 至 2006-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6661324
• 关键词: Animalia; clinical research; education evaluation /planning; health science research; health science research support; human subject; neoplasm /cancer; neoplasm /cancer education; oncology

APPLICANT'S DESCRIPTION: Cancer research, in the genome era, is undergoing a dramatic and rapid metamorphosis. But the new discoveries in cancer biology and genetics must be translated properly into cancer practice through sound research. Unfortunately, academically prepared clinician investigators, to conduct such research, are in short supply. The NCI's program announcement PAR 99-077, "Clinical Oncology Research Career Development Program," is designed to increase the number of medical doctors and doctorally degreed oncology nurses to serve this clinical-translational interface. Mayo Clinic is a highly respected center for medical training, research and patient care. The Mayo environment has the key elements needed for an outstanding training program in clinical-translational research: The Mayo Clinic Cancer Center (MCCC), an NCI-designated comprehensive cancer center, has had continuous funding from NCI for over 25 years - the center is vital and growing, experiencing a 250% increase in its NCI funding since 1994. It is recognized that particularly for the quality of its clinical research, clinical trials, and translational research; Mayo is world-renowned as a center for medical training - its Graduate School of Medicine is the largest residency training program in the world, teaching 1200 physicians each year in over 100 specialties; and Mayo has an outstanding K30 program, delivering the didactic elements necessary for clinical-translational research training. With the proposed Mayo Clinical Oncology Research Training Program, we will build upon our Comprehensive Cancer Center and K30 infrastructures to develop a combined didactic-mentored training program in clinical and translational cancer research. This proposed program represents the first cancer research training program for clinicians at Mayo. We have brought together an exceptional group of researchers and mentors, organized in already existing multidisciplinary teams. Research plans for fellows can be designed in breast cancer, GI cancer, genetics/family studies, hematology, neuro-oncology, nicotine dependence, novel therapeutics, ovarian cancer, population sciences/outcomes research, prostate cancer, and symptom control/QOL. With this program, we will train clinician investigators who will have a solid understanding of high quality clinical research, who can design and manage all phases of clinical trials, and who can partner with basic, population and/or behavioral scientists to translate discoveries into better medical care.

申请人描述：基因组时代的癌症研究正在经历一场变革 戏剧性和快速的转变。 但癌症生物学的新发现 遗传学必须通过声音正确转化为癌症实践 研究。 不幸的是，学术上做好准备的临床研究人员， 进行这样的研究，目前供不应求。 NCI 计划公告 PAR 99-077，“临床肿瘤学研究职业发展计划” 旨在增加医生和博士学位的数量 肿瘤科护士为这种临床转化界面提供服务。 梅奥诊所是备受推崇的医疗培训、研究和治疗中心 病人护理。 Mayo 环境具有实现以下目标所需的关键要素： 临床转化研究杰出培训计划：梅奥 临床癌症中心 (MCCC) 是 NCI 指定的综合性癌症中心， 25 年来一直得到 NCI 的持续资助 - 该中心至关重要 自 1994 年以来，NCI 的资金增长了 250%。 公认的是，特别是其临床研究的质量， 临床试验和转化研究；梅奥是享誉世界的 医学培训中心 - 其医学研究生院是最大的 世界各地的住院医师培训计划，每年为 1200 名医生提供培训 100多个专业；梅奥拥有出色的 K30 计划，可提供 临床转化研究培训所需的教学要素。 通过拟议的梅奥临床肿瘤学研究培训计划，我们将 以我们的综合癌症中心和 K30 基础设施为基础，开发 临床和转化方面的联合教学指导培训计划 癌症研究。 这个拟议的计划代表了第一个癌症研究 梅奥临床医生培训计划。 我们汇集了 由现有的研究人员和导师组成的杰出团队 多学科团队。 可以为研究员设计研究计划 癌症、胃肠道癌症、遗传学/家庭研究、血液学、神经肿瘤学、 尼古丁依赖、新疗法、卵巢癌、人口 科学/结果研究、前列腺癌和症状控制/生活质量。 和 在这个项目中，我们将培训临床研究人员，他们将拥有坚实的基础 了解高质量的临床研究，可以设计和管理所有 临床试验的各个阶段，以及谁可以与基础、人群和/或 行为科学家将发现转化为更好的医疗保健。